Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Fidrus Eszter

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2017-2025

2025

Papp, B., Józsa, L., Sinka, D. Z., Fidrus, E., Kardos, G., Nacsa, F., Bácskay, I., Fehér, P.: Formulation and investigation of Lactobacillus rhamnosus cek-R1 filled alginate microspheres with different excipients.
DRem. 1 (2), 1-16, 2025.

doi DEA

Bodnár, K., Fehér, P., Ujhelyi, Z., Haimhoffer, Á., Papp, B., Sinka, D. Z., Freytag, C., Fidrus, E., Szarka, K., Kardos, G., Nacsa, F., Bácskay, I., Józsa, L.: Formulation and Testing of Alginate Microbeads Containing Salvia officinalis Extract and Prebiotics.
Pharmaceutics. 17 (10), 1-33, (article identifier: 1308), 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2024)

2023

Mudambi, S., Fitzgerald, M. E., Pera, P., Washington, D., Chamberlain, S., Fidrus, E., Hegedűs, C., Remenyik, É., Shafirstein, G., Bellnier, D., Paragh, G. J.: KDM1A inhibition increases UVA toxicity and enhances photodynamic therapy efficacy.
Photodermatol. Photoimmunol. Photomed. 39 (3), 226-234, 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Dermatology

Q3 Immunology

Q3 Immunology and Allergy

Q2 Medicine (miscellaneous)

Q2 Radiology, Nuclear Medicine and Imaging

2022

Kaszab, E., Laczkó, L., Bali, K., Fidrus, E., Bányai, K., Kardos, G.: Draft Genome Sequences of Lacticaseibacillus rhamnosus cek-R1, Lacticaseibacillus paracasei cek-R2, and Lentilactobacillus otakiensis cek-R3, Isolated from a Beetroot Product.
Microbiol Resour Announc. 11 (1), e00921-21, (article identifier: 00921), 2022.

doi DEA WoS Scopus

Journal metrics:

Q4 Genetics

Q3 Immunology and Microbiology (miscellaneous)

Q4 Molecular Biology

2021

Hegedűs, C., Juhász, T., Fidrus, E., Janka, E. A., Juhász, G., Boros, G., Paragh, G. J., Uray, K., Emri, G., Remenyik, É., Bai, P.: Cyclobutane pyrimidine dimers from UVB exposure induce a hypermetabolic state in keratinocytes via mitochondrial oxidative stress.
Redox Biol. 38, 1-17, (article identifier: 101808), 2021.

DEA WoS Scopus

Journal metrics:

D1 Biochemistry

D1 Clinical Biochemistry

D1 Organic Chemistry

Fidrus, E., Hegedűs, C., Janka, E. A., Paragh, G., Emri, G., Remenyik, É.: Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis - an In Vitro Study.
Int. J. Mol. Sci. 22 (4), 1-17, (article identifier: 1638), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2020

Hegedűs, C., Boros, G., Fidrus, E., Kis, G., Antal, M., Juhász, T., Janka, E. A., Jankó, L., Paragh, G. J., Emri, G., Bai, P., Remenyik, É.: PARP1 Inhibition Augments UVB-Mediated Mitochondrial Changes-Implications for UV-Induced DNA Repair and Photocarcinogenesis.
Cancers (Basel). 12 (1), 5, (article identifier: 5), 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Cancer Research

Q1 Oncology

2019

Gellén, E., Fidrus, E., Janka, E. A., Kollár, S., Paragh, G. J., Emri, G., Remenyik, É.: 5-Aminolevulinic acid photodynamic therapy with and without Er:YAG laser for actinic keratosis: changes in immune infiltration.
Photodiagnosis Photodyn. Ther. 26, 270-276, 2019.

doi DEA

Journal metrics:

Q2 Biophysics

Q2 Dermatology

Q3 Oncology

Q2 Pharmacology (medical)

Fidrus, E., Fehér, P., Hegedűs, C., Janka, E. A., Paragh, G. J., Bácskay, I., Remenyik, É.: Enhanced UVA-induced cyclobutane pyrimidine dimer formation by silymarin without increased mutagenesis in cultured epithelial cells.
J. Invest. Dermatol. 139 (9), S311, 2019.

doi DEA WoS

10.

Hegedűs, C., Boros, G., Janka, E. A., Fidrus, E., Juhász, T., Karikó, K., Emri, G., Bai, P., Remenyik, É.: In vitro delivery of CPD-specific photolyase-encoding mRNA prevents UVB-induced mitochondrial changes.
J. Invest. Dermatol. 139 (9), S309, 2019.

doi DEA WoS

11.

Fidrus, E., Ujhelyi, Z., Fehér, P., Hegedűs, C., Janka, E. A., Paragh, G. J., Vasas, G., Bácskay, I., Remenyik, É.: Silymarin: friend or foe of UV exposed keratinocytes?.
Molecules. 24 (9), 1-12, (article identifier: 1652), 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

12.

Fidrus, E., Boros, G., Hegedűs, C., Janka, E. A., Emri, G., Karikó, K., Remenyik, É.: Time-dependence of UVB induced cellular mechanisms in cultured human keratinocytes.
J. Invest. Dermatol. 139 (9), S311, 2019.

doi DEA WoS

13.

Fidrus, E., Hegedűs, C., Janka, E. A., Emri, G., Remenyik, É.: UV mutagenezis és repair gátlás vizsgálata in vitro.
Bőrgyógyász. venerol. szle. 95 (6), 272, 2019.

DEA

2018

14.

Fidrus, E., Boros, G., Hegedűs, C., Janka, E. A., Emri, G., Karikó, K., Remenyik, É.: Az UVB sugárzást követő, CPD-kapcsolt folyamatok in vitro időfüggő vizsgálata.
Bőrgyógyász. venerol. szle. 94 (6), 288, 2018.

DEA

15.

Gellén, E., Fidrus, E., Péter, M., Szegedi, A., Emri, G., Remenyik, É.: Immunological effects of photodynamic therapy in the treatment of actinic keratosis and squamous cell carcinoma.
Photodiagnosis Photodyn. Ther. 24, 342-348, 2018.

DEA

Journal metrics:

Q2 Biophysics

Q2 Dermatology

Q3 Oncology

Q2 Pharmacology (medical)

16.

Mudambi, S., Pera, P., Washington, D., Remenyik, É., Fidrus, E., Shafirstein, G., Bellnier, D., Paragh, G. J.: Photodynamic therapy does not induce cyclobutane pyrimidine dimers in the presence of melanin.
Photodiagnosis Photodyn. Ther. 22, 241-244, 2018.

DEA

Journal metrics:

Q2 Biophysics

Q2 Dermatology

Q3 Oncology

Q2 Pharmacology (medical)

2017

17.

Gellén, E., Fidrus, E., Janka, E. A., Barta, B., Emri, G., Remenyik, É.: 642 Efficacy and photorejuvenation effect of conventional photodynamic therapy (PDT) and Er:YAG (erbium:yttrium-aluminium-garnet) ablative fractional laser - assisted PDT in multiple actinic keratosis.
J. Invest. Dermatol. 137 (10), S302-, 2017.

doi DEA

18.

Gellén, E., Kollár, S., Péter, M., Fidrus, E., Janka, E. A., Emri, G., Remenyik, É.: Aktinikus keratosis immun infiltrátumának vizsgálata photodynámiás terápia előtt és után.
Bőrgyógyász. venerol. szle. 93 (6), 263, 2017.

DEA

19.

Szemán-Nagy, G., Tánczos, B., Fidrus, E., Tálas, L., Bánfalvi, G.: Chemically Induced Cell Cycle Arrest in Perfusion Cell Culture.
In: Cell cycle synchronization : methods and protocols. Ed.: by Gaspar Banfalvi, Humana Press, New York, 161-176, 2017. ISBN: 9781493966035

doi DEA

20.

Tálas, L., Bánfalvi, G., Fidrus, E., Máthéné Szigeti, Z., Szemán-Nagy, G.: Mycoplasma infection followed by time-lapse microscopy.
Med. Hypotheses. 108, 154-158, 2017.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

21.

Péter, M., Boros, G., Hegedűs, C., Fidrus, E., Emri, G., Karikó, K., Remenyik, É.: Time-dependent investigation of UVB-induced cellular mechanisms in human keratinocytes using mRNA encoding cyclobutane pyrimidine dimer-specific photolyase.
J. Invest. Dermatol. 137 (10), S301, 2017.

doi DEA WoS